Hanson McClain Advisors »

Heron Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $834 301 2.77
2023-12-31 $512 301 1.70
2021-09-30 $2.0k 150 13.33
2021-06-30 $2.0k 150 13.33
2021-03-31 $2.0k 150 13.33
2020-12-31 $3.0k 150 20.00